Company / Inventory
AMICUS THERAPEUTICS, INC. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$228.8M
FY2025
5-year range
$23.8M / $228.8M
FY2021-FY2025
Trend
+92.6%
vs FY2024
Sector context
#27 of 105
Health Care
What the data says
At $229M, AMICUS THERAPEUTICS, INC.'s inventory ranks #27 of 105 in the Health Care sector. Inventory has increased for 3 consecutive years, from $24M in FY2022 to $229M in FY2025.
Based on SEC 10-K filings.
$229M in FY2025 with a 5-year CAGR of +63.5%. Top quartile in the Health Care sector.
Improved from $60M to $229M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +112.6%
- 5-Year CAGR
- +63.5%
- 10-Year CAGR
- -
Sector benchmark
#27 of 105 in Health CareTop 26% of 105This company $228.8M Sector average $885.3M
▼
-74.2% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s inventory has grown for 3 consecutive years.
- 5-year CAGR of +63.5%, indicating consistent growth.
- In FY2025, inventory increased 92.6% year-over-year.
- Ranks #27 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $228.8M | +92.6% |
| FY2024 | $118.8M | +99.0% |
| FY2023 | $59.7M | +150.7% |
| FY2022 | $23.8M | -11.2% |
| FY2021 | $26.8M | +37.1% |
| FY2020 | $19.6M | +39.3% |
| FY2019 | $14.0M | +67.4% |
| FY2018 | $8.4M | +81.5% |
| FY2017 | $4.6M | +35.3% |
| FY2016 | $3.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026